BDR Pharma launches patient-friendly prostrate cancer therapy

1 year ago 47

India Business News: BDR Pharma launches BDENZA (Enzalutamide), the world's first oral solution for prostate cancer management. BDENZA is priced at Rs 27,000 for 150mL, of

1. Homepage
2. Prostate Cancer
3. BDR Pharma launches patient-friendly prostrate cancer therapy